Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
Charles Miller, Hanson Kwok, Paul Harrow, Roser Vega, Edward Seward, Shameer Mehta, Farooq Rahman, Sara McCartney, Ioanna Parisi, Samuel Hsiang Lim, Esha Sharma, Mark A Samaan, Aaron Bancil, Klaartje Bel Kok, Ahmed Shalabi, Emma L Johnston, Dev Katarey, Nina Taherzadeh, Charles Murray, Mohammed Tauseef Sharip, Martyn J Carter, Shiva T Radhakrishnan, Simon Peake, Imran Khakoo, Mahmood Wahed, Sebastian Povlsen, Mehul Patel, Patrick DuBois, Jemima Finkel, Clive Onnie, Stuart Bloom
Frontline Gastroenterology Sep 2022, 13 (5) 392-401; DOI: 10.1136/flgastro-2021-101906